Free Trial

Braze (BRZE) Financials

Braze logo
$28.33 -0.70 (-2.41%)
As of 04/14/2025 04:00 PM Eastern
Annual Income Statements for Braze

Annual Income Statements for Braze

This table shows Braze's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Net Income / (Loss) Attributable to Common Shareholders
-32 -32 -77 -139 -129 -104
Consolidated Net Income / (Loss)
-32 -32 -78 -141 -130 -104
Net Income / (Loss) Continuing Operations
-32 -32 -78 -141 -130 -104
Total Pre-Tax Income
-31 -31 -78 -140 -128 -101
Total Operating Income
-34 -32 -78 -148 -145 -122
Total Gross Profit
61 96 160 240 324 410
Total Revenue
96 150 238 355 472 593
Operating Revenue
96 150 238 355 472 593
Total Cost of Revenue
36 55 79 116 148 183
Operating Cost of Revenue
36 55 79 116 148 183
Total Operating Expenses
94 128 238 388 469 532
Selling, General & Admin Expense
17 28 52 89 102 116
Marketing Expense
57 71 127 202 247 282
Research & Development Expense
20 29 59 97 120 134
Total Other Income / (Expense), net
2.18 0.72 -0.12 7.98 16 22
Other Income / (Expense), net
0.05 0.72 -0.12 7.98 16 22
Income Tax Expense
0.45 0.54 -0.17 0.58 1.96 3.45
Net Income / (Loss) Attributable to Noncontrolling Interest
0.00 -0.22 -1.45 -1.78 -1.26 -0.30
Basic Earnings per Share
($1.96) ($1.77) ($2.20) ($1.47) ($1.32) ($1.02)
Weighted Average Basic Shares Outstanding
16.19M 17.97M 34.90M 94.57M 98.10M 102.19M
Diluted Earnings per Share
($1.96) ($1.77) ($2.20) ($1.47) ($1.32) ($1.02)
Weighted Average Diluted Shares Outstanding
16.19M 17.97M 34.90M 94.57M 98.10M 102.19M
Weighted Average Basic & Diluted Shares Outstanding
- - 93.23M 96.23M 100.84M 104.63M

Quarterly Income Statements for Braze

This table shows Braze's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Net Income / (Loss) Attributable to Common Shareholders
-33 -33 -33 -38 -32 -31 -28 -36 -23 -28 -17
Consolidated Net Income / (Loss)
-33 -34 -34 -39 -32 -31 -29 -36 -23 -28 -17
Net Income / (Loss) Continuing Operations
-33 -34 -34 -39 -32 -31 -29 -36 -23 -28 -17
Total Pre-Tax Income
-33 -34 -33 -38 -32 -31 -28 -35 -22 -27 -16
Total Operating Income
-35 -37 -37 -42 -35 -35 -32 -40 -28 -33 -22
Total Gross Profit
59 64 65 69 80 88 88 91 102 106 111
Total Revenue
86 93 99 102 115 124 131 135 145 152 160
Operating Revenue
86 93 99 102 115 124 131 135 145 152 160
Total Cost of Revenue
27 29 33 33 35 36 43 45 43 46 49
Operating Cost of Revenue
27 29 33 33 35 36 43 45 43 46 49
Total Operating Expenses
94 101 102 111 115 123 120 131 130 139 133
Selling, General & Admin Expense
21 22 22 24 25 26 26 27 28 31 30
Marketing Expense
50 53 53 57 60 66 63 70 69 75 69
Research & Development Expense
23 26 27 30 29 30 31 34 33 33 34
Total Other Income / (Expense), net
1.73 2.58 3.64 3.46 3.87 4.54 4.35 5.17 5.50 5.29 5.59
Other Income / (Expense), net
1.73 2.58 3.64 3.46 3.87 4.54 4.35 5.17 5.50 5.29 5.59
Income Tax Expense
0.00 -0.39 0.97 0.39 0.55 0.39 0.64 0.80 0.70 0.85 1.09
Net Income / (Loss) Attributable to Noncontrolling Interest
-0.53 -0.53 -0.36 -0.37 -0.36 -0.24 -0.30 -0.07 -0.15 -0.22 0.13
Basic Earnings per Share
($0.35) ($0.35) ($0.35) ($0.40) ($0.33) ($0.31) ($0.28) ($0.35) ($0.23) ($0.27) ($0.17)
Weighted Average Basic Shares Outstanding
94.10M 94.47M 94.57M 96.35M 97.18M 97.88M 98.10M 100.79M 101.45M 102.15M 102.19M
Diluted Earnings per Share
($0.35) ($0.35) ($0.35) ($0.40) ($0.33) ($0.31) ($0.28) ($0.35) ($0.23) ($0.27) ($0.17)
Weighted Average Diluted Shares Outstanding
94.10M 94.47M 94.57M 96.35M 97.18M 97.88M 98.10M 100.79M 101.45M 102.15M 102.19M
Weighted Average Basic & Diluted Shares Outstanding
95.04M 95.71M 96.23M 97.59M 98.87M 99.84M 100.84M 101.63M 102.73M 103.48M 104.63M

Annual Cash Flow Statements for Braze

This table details how cash moves in and out of Braze's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Net Change in Cash & Equivalents
-93 21 450 -410 -0.49 11
Net Cash From Operating Activities
-7.37 -6.08 -35 -22 6.85 37
Net Cash From Continuing Operating Activities
-7.37 -6.08 -35 -22 6.85 37
Net Income / (Loss) Continuing Operations
-32 -32 -78 -141 -130 -104
Consolidated Net Income / (Loss)
-32 -32 -78 -141 -130 -104
Depreciation Expense
0.65 1.59 2.77 4.62 6.96 10
Amortization Expense
5.33 11 18 25 28 33
Non-Cash Adjustments To Reconcile Net Income
13 8.68 48 79 103 121
Changes in Operating Assets and Liabilities, net
5.27 4.66 -26 9.43 -0.52 -23
Net Cash From Investing Activities
-87 22 18 -399 -20 -36
Net Cash From Continuing Investing Activities
-87 22 18 -399 -20 -36
Purchase of Property, Plant & Equipment
-2.55 -4.35 -4.38 -17 -13 -17
Acquisitions
- - 0.00 0.00 -16 0.00
Purchase of Investments
-123 -59 -37 -638 -248 -218
Sale and/or Maturity of Investments
38 86 59 256 258 199
Net Cash From Financing Activities
1.26 4.87 468 11 13 12
Net Cash From Continuing Financing Activities
1.26 4.87 468 11 13 12
Issuance of Common Equity
0.00 2.45 460 0.00 6.01 7.71
Other Financing Activities, net
1.27 2.81 8.36 11 7.10 3.99
Effect of Exchange Rate Changes
0.02 0.16 -0.60 -0.86 -0.48 -0.44
Cash Income Taxes Paid
0.18 0.47 0.30 0.37 0.31 2.95

Quarterly Cash Flow Statements for Braze

This table details how cash moves in and out of Braze's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Net Change in Cash & Equivalents
-9.73 -35 23 49 -40 -17 7.76 6.57 0.95 -18 22
Net Cash From Operating Activities
-16 -24 0.01 23 -18 -2.00 3.82 19 12 -11 17
Net Cash From Continuing Operating Activities
-16 -24 -0.02 23 -18 -2.00 3.82 19 12 -11 17
Net Income / (Loss) Continuing Operations
-33 -34 -34 -39 -32 -31 -29 -36 -23 -28 -17
Consolidated Net Income / (Loss)
-33 -34 -34 -39 -32 -31 -29 -36 -23 -28 -17
Depreciation Expense
0.94 1.03 1.69 1.53 1.32 2.24 1.88 2.13 2.61 2.64 2.75
Amortization Expense
5.78 6.80 6.97 7.13 7.80 8.33 4.45 7.83 8.11 8.46 8.54
Non-Cash Adjustments To Reconcile Net Income
17 21 20 25 27 25 25 29 31 31 29
Changes in Operating Assets and Liabilities, net
-6.65 -19 5.09 28 -22 -7.01 0.62 16 -7.24 -26 -5.95
Net Cash From Investing Activities
4.00 -13 18 24 -28 -16 -0.50 -11 -17 -8.20 -0.84
Net Cash From Continuing Investing Activities
4.00 -13 18 24 -28 -16 -0.50 -11 -17 -8.20 -0.84
Purchase of Property, Plant & Equipment
-8.36 -4.14 -1.93 -0.89 -1.18 -3.91 -7.36 -7.95 -4.38 -2.84 -1.88
Purchase of Investments
-122 -71 -23 -46 -75 -71 -56 -60 -82 -37 -38
Sale and/or Maturity of Investments
135 62 43 71 65 58 63 57 70 32 39
Net Cash From Financing Activities
2.78 1.80 4.12 2.21 5.12 1.67 4.10 -1.88 5.92 1.48 6.18
Net Cash From Continuing Financing Activities
2.78 1.80 4.12 2.21 5.12 1.67 4.10 -1.88 5.92 1.48 6.18
Issuance of Common Equity
- - - - - 3.22 2.79 - - - 2.95
Other Financing Activities, net
2.78 1.80 4.12 2.21 5.12 -1.55 1.31 -1.88 1.17 1.48 3.22
Effect of Exchange Rate Changes
-0.19 -0.63 1.04 -0.18 -0.12 -0.51 0.33 -0.34 0.24 0.32 -0.67
Cash Income Taxes Paid
0.15 0.01 0.04 -0.47 0.55 0.10 0.13 1.58 0.38 0.56 0.43

Annual Balance Sheets for Braze

This table presents Braze's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024 2025
Total Assets
171 666 705 811 871
Total Current Assets
134 608 583 601 644
Cash & Equivalents
29 479 69 68 83
Restricted Cash
0.47 - 0.00 3.37 0.00
Short-Term Investments
58 35 410 408 430
Accounts Receivable
35 65 78 92 95
Prepaid Expenses
12 30 26 29 35
Plant, Property, & Equipment, net
5.49 7.39 20 29 39
Total Noncurrent Assets
32 51 102 180 188
Goodwill
- - 0.00 28 28
Intangible Assets
- - 0.50 3.69 3.13
Other Noncurrent Operating Assets
32 51 101 148 157
Total Liabilities & Shareholders' Equity
171 666 705 811 871
Total Liabilities
103 161 259 367 396
Total Current Liabilities
101 160 217 289 324
Accounts Payable
0.44 2.08 3.10 6.32 2.15
Accrued Expenses
26 32 37 63 64
Current Deferred Revenue
75 126 166 204 240
Other Current Liabilities
- 0.00 11 16 18
Total Noncurrent Liabilities
2.31 1.48 41 77 72
Other Noncurrent Operating Liabilities
2.23 1.48 41 77 72
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest
176 3.24 1.46 0.19 -0.11
Total Equity & Noncontrolling Interests
-109 502 445 444 475
Total Preferred & Common Equity
-109 502 445 444 475
Total Common Equity
-109 502 445 444 475
Common Stock
30 717 806 929 1,063
Retained Earnings
-138 -215 -354 -483 -587
Accumulated Other Comprehensive Income / (Loss)
-0.04 -0.64 -6.82 -1.18 -0.93

Quarterly Balance Sheets for Braze

This table presents Braze's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025
Total Assets
184 716 702 677 721 732 769 816 826 842
Total Current Assets
131 599 581 556 598 574 567 599 606 613
Cash & Equivalents
42 91 81 45 117 77 60 75 79 61
Restricted Cash
0.00 - - - 3.37 3.37 3.37 3.37 0.00 0.00
Short-Term Investments
35 439 426 428 386 395 408 409 425 431
Accounts Receivable
36 43 48 58 67 70 71 82 71 90
Prepaid Expenses
18 26 26 24 25 28 24 30 31 30
Plant, Property, & Equipment, net
6.29 9.50 16 20 20 21 23 39 40 40
Total Noncurrent Assets
47 108 105 101 103 137 179 178 180 189
Goodwill
- - - - - 28 28 28 28 28
Intangible Assets
- - - - - 4.12 3.91 3.47 3.33 3.23
Other Noncurrent Operating Assets
47 108 105 101 103 105 147 146 148 157
Total Liabilities & Shareholders' Equity
184 716 702 677 721 732 769 816 826 842
Total Liabilities
125 229 229 223 285 291 330 380 372 384
Total Current Liabilities
122 181 184 182 245 248 248 306 298 308
Accounts Payable
1.20 2.68 2.89 2.06 3.57 1.88 5.95 4.69 4.47 2.91
Accrued Expenses
23 29 35 28 47 56 50 56 65 63
Current Deferred Revenue
98 139 136 141 181 177 179 229 212 224
Other Current Liabilities
- 9.99 11 11 13 14 14 15 16 18
Total Noncurrent Liabilities
2.26 48 45 42 40 43 82 74 74 76
Other Noncurrent Operating Liabilities
2.20 48 45 42 40 43 82 74 74 76
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest
178 2.87 2.34 1.81 1.08 0.73 0.49 0.13 -0.02 -0.24
Total Equity & Noncontrolling Interests
-118 485 471 452 435 440 438 436 454 458
Total Preferred & Common Equity
-118 485 471 452 435 440 438 436 454 458
Total Common Equity
-118 485 471 452 435 440 438 436 454 458
Common Stock
54 741 761 783 833 870 898 958 996 1,027
Retained Earnings
-172 -254 -287 -320 -392 -424 -455 -519 -542 -570
Accumulated Other Comprehensive Income / (Loss)
-0.29 -2.40 -3.75 -9.87 -5.31 -5.88 -5.19 -3.39 -0.25 0.35

Annual Metrics and Ratios for Braze

This table displays calculated financial ratios and metrics derived from Braze's official financial filings.

Metric 2020 2021 2022 2023 2024 2025
Growth Metrics
- - - - - -
Revenue Growth
0.00% 55.86% 58.49% 49.32% 32.74% 25.78%
EBITDA Growth
0.00% 31.37% -204.43% -92.36% 15.17% 38.64%
EBIT Growth
0.00% 6.13% -149.21% -78.93% 8.34% 21.69%
NOPAT Growth
0.00% 4.12% -143.25% -89.41% 2.33% 15.57%
Net Income Growth
0.00% -0.50% -144.51% -80.06% 7.33% 20.23%
EPS Growth
0.00% 9.69% -24.29% 33.18% 10.20% 22.73%
Operating Cash Flow Growth
0.00% 17.45% -482.20% 36.98% 130.71% 435.47%
Free Cash Flow Firm Growth
0.00% 0.00% -1,755.45% -25.67% -21.05% 16.62%
Invested Capital Growth
0.00% 0.00% 51.26% -244.06% -9.91% -10.54%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 8.63% 7.34% 5.22%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% 10.35% 2.70% 22.72%
EBIT Q/Q Growth
0.00% 0.00% 0.00% 6.25% 3.71% 10.63%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% 3.93% 2.84% 8.08%
Net Income Q/Q Growth
0.00% 0.00% 0.00% 6.34% 3.86% 9.96%
EPS Q/Q Growth
0.00% 0.00% 0.00% 10.91% 5.04% 9.73%
Operating Cash Flow Q/Q Growth
0.00% 0.00% -226.31% 52.38% 125.25% 56.63%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% -7.79% 9.97%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% -64.50% -7.55% -11.55%
Profitability Metrics
- - - - - -
Gross Margin
62.97% 63.71% 67.02% 67.41% 68.73% 69.13%
EBITDA Margin
-28.55% -12.57% -24.15% -31.11% -19.88% -9.70%
Operating Margin
-34.80% -21.41% -32.86% -41.68% -30.67% -20.59%
EBIT Margin
-34.75% -20.93% -32.91% -39.44% -27.23% -16.95%
Profit (Net Income) Margin
-33.01% -21.29% -32.84% -39.60% -27.65% -17.53%
Tax Burden Percent
101.44% 101.71% 99.79% 100.42% 101.52% 103.42%
Interest Burden Percent
93.65% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)
0.00% -47.04% -27.29% -29.58% -29.27% -22.64%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)
0.00% -18.34% -18.70% -20.44% -16.94% -11.96%
Return on Assets (ROA)
0.00% -18.65% -18.66% -20.52% -17.20% -12.37%
Return on Common Equity (ROCE)
0.00% 75.12% -18.73% -29.44% -29.22% -22.64%
Return on Equity Simple (ROE_SIMPLE)
0.00% 29.46% -15.58% -31.61% -29.36% -21.91%
Net Operating Profit after Tax (NOPAT)
-23 -23 -55 -104 -101 -86
NOPAT Margin
-24.36% -14.99% -23.00% -29.18% -21.47% -14.41%
Net Nonoperating Expense Percent (NNEP)
0.00% -21.76% -7.79% -7.46% -6.08% -3.73%
Return On Investment Capital (ROIC_SIMPLE)
- - - -23.29% -22.80% -18.01%
Cost of Revenue to Revenue
37.03% 36.29% 32.98% 32.59% 31.27% 30.87%
SG&A Expenses to Revenue
17.15% 18.62% 21.66% 24.98% 21.61% 19.56%
R&D to Revenue
21.11% 19.45% 24.80% 27.37% 25.41% 22.58%
Operating Expenses to Revenue
97.77% 85.11% 99.87% 109.09% 99.40% 89.72%
Earnings before Interest and Taxes (EBIT)
-33 -31 -78 -140 -128 -101
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-28 -19 -57 -111 -94 -58
Valuation Ratios
- - - - - -
Price to Book Value (P/BV)
0.00 0.00 9.19 6.88 12.15 10.02
Price to Tangible Book Value (P/TBV)
0.00 0.00 9.19 6.89 13.10 10.73
Price to Revenue (P/Rev)
5.40 3.46 19.36 8.62 11.44 8.02
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
0.00 4.06 17.21 7.27 10.42 7.15
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 717.84 115.72
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
0.00 -1.28 -1.05 -1.04 -1.08 -1.08
Leverage Ratio
0.00 2.52 1.46 1.44 1.70 1.83
Compound Leverage Factor
0.00 2.52 1.46 1.44 1.70 1.83
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 259.67% 0.64% 0.33% 0.04% -0.02%
Common Equity to Total Capital
0.00% -159.67% 99.36% 99.67% 99.96% 100.02%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
0.00 2.39 17.45 6.87 8.52 7.00
Noncontrolling Interest Sharing Ratio
0.00% 259.67% 31.37% 0.49% 0.18% 0.01%
Liquidity Ratios
- - - - - -
Current Ratio
0.00 1.32 3.80 2.68 2.08 1.98
Quick Ratio
0.00 1.20 3.62 2.56 1.96 1.88
Cash Flow Metrics
- - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -3.48 -65 -81 -98 -82
Operating Cash Flow to CapEx
-288.37% -139.71% -809.10% -133.54% 51.37% 215.16%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - -
Asset Turnover
0.00 0.88 0.57 0.52 0.62 0.71
Accounts Receivable Turnover
0.00 4.32 4.80 4.98 5.53 6.33
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 27.38 36.96 25.63 18.99 17.48
Accounts Payable Turnover
0.00 124.17 62.26 44.68 31.32 43.25
Days Sales Outstanding (DSO)
0.00 84.50 76.11 73.34 65.99 57.66
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 2.94 5.86 8.17 11.66 8.44
Cash Conversion Cycle (CCC)
0.00 81.56 70.25 65.18 54.33 49.22
Capital & Investment Metrics
- - - - - -
Invested Capital
0.00 -19 -9.28 -32 -35 -39
Invested Capital Turnover
0.00 -15.78 -16.82 -17.26 -14.09 -16.07
Increase / (Decrease) in Invested Capital
0.00 -19 9.76 -23 -3.16 -3.70
Enterprise Value (EV)
0.00 609 4,096 2,585 4,917 4,245
Market Capitalization
520 520 4,607 3,063 5,396 4,758
Book Value per Share
$0.00 ($6.04) $5.45 $4.65 $4.45 $4.59
Tangible Book Value per Share
$0.00 ($6.04) $5.45 $4.65 $4.13 $4.28
Total Capital
0.00 68 505 447 444 475
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
0.00 -87 -514 -479 -479 -514
Capital Expenditures (CapEx)
2.55 4.35 4.38 17 13 17
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 -54 -66 -113 -168 -194
Debt-free Net Working Capital (DFNWC)
0.00 33 448 366 312 320
Net Working Capital (NWC)
0.00 33 448 366 312 320
Net Nonoperating Expense (NNE)
8.34 9.46 23 37 29 19
Net Nonoperating Obligations (NNO)
0.00 -87 -514 -479 -479 -514
Total Depreciation and Amortization (D&A)
5.97 13 21 30 35 43
Debt-free, Cash-free Net Working Capital to Revenue
0.00% -36.06% -27.67% -31.74% -35.57% -32.69%
Debt-free Net Working Capital to Revenue
0.00% 21.86% 188.30% 102.94% 66.06% 53.85%
Net Working Capital to Revenue
0.00% 21.86% 188.30% 102.94% 66.06% 53.85%
Earnings Adjustments
- - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 ($2.20) ($1.47) ($1.32) ($1.02)
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 34.90M 94.57M 98.10M 102.19M
Adjusted Diluted Earnings per Share
$0.00 $0.00 ($2.20) ($1.47) ($1.32) ($1.02)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 34.90M 94.57M 98.10M 102.19M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 93.23M 96.23M 100.84M 104.63M
Normalized Net Operating Profit after Tax (NOPAT)
-23 -23 -55 -104 -101 -86
Normalized NOPAT Margin
-24.36% -14.99% -23.00% -29.18% -21.47% -14.41%
Pre Tax Income Margin
-32.54% -20.93% -32.91% -39.44% -27.23% -16.95%
Debt Service Ratios
- - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
-0.03% -1.24% -0.01% 0.00% 0.00% 0.00%

Quarterly Metrics and Ratios for Braze

This table displays calculated financial ratios and metrics derived from Braze's official financial filings.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
54.48% 45.58% 40.10% 31.34% 33.64% 33.11% 32.72% 33.09% 26.40% 22.67% 22.48%
EBITDA Growth
-261.40% -466.00% 34.52% 10.39% 16.05% 24.31% 10.77% 16.20% 47.59% 19.21% 78.31%
EBIT Growth
-168.16% -221.42% 22.13% 2.98% 5.61% 10.77% 15.04% 9.18% 28.75% 10.84% 42.84%
NOPAT Growth
-188.95% -252.83% 14.25% -5.67% -0.75% 4.70% 11.57% 4.34% 20.98% 7.30% 33.24%
Net Income Growth
-164.91% -274.17% 22.00% 2.04% 4.08% 8.60% 15.47% 8.03% 27.77% 9.20% 40.29%
EPS Growth
41.67% 16.67% 33.96% 4.76% 5.71% 11.43% 20.00% 12.50% 30.30% 12.90% 39.29%
Operating Cash Flow Growth
-254.27% -874.74% 100.05% 25.82% -7.33% 91.63% 31,741.67% -13.99% 166.29% -469.65% 347.08%
Free Cash Flow Firm Growth
0.00% -334.74% 0.00% -113.10% -361.60% 52.39% -564.27% -2,330.47% 84.41% -81.49% 41.39%
Invested Capital Growth
0.00% -10.88% -244.06% -64.37% -2.32% -68.11% -9.91% 27.23% -45.85% -6.58% -10.54%
Revenue Q/Q Growth
11.14% 8.12% 5.96% 3.15% 13.09% 7.69% 5.65% 3.44% 7.41% 4.50% 5.49%
EBITDA Q/Q Growth
19.77% 0.78% 8.46% -22.98% 24.84% 10.55% -7.93% -15.49% 53.00% -37.90% 71.03%
EBIT Q/Q Growth
15.75% -2.71% 4.08% -16.89% 18.04% 2.90% 8.67% -24.95% 35.70% -21.51% 41.45%
NOPAT Q/Q Growth
11.46% -5.00% 0.93% -14.72% 15.58% 0.67% 8.08% -24.11% 30.26% -16.53% 33.81%
Net Income Q/Q Growth
15.69% -1.43% 0.25% -14.84% 17.45% 3.35% 7.74% -24.95% 35.17% -21.50% 39.33%
EPS Q/Q Growth
16.67% 0.00% 0.00% -14.29% 17.50% 6.06% 9.68% -25.00% 34.29% -17.39% 37.04%
Operating Cash Flow Q/Q Growth
-191.07% -46.56% 100.05% 187,808.33% -177.68% 88.57% 290.76% 407.59% -40.13% -198.26% 249.72%
Free Cash Flow Firm Q/Q Growth
-38.06% -360.79% 87.75% 33.79% -1,137.23% 52.54% -70.85% -142.25% 92.07% -452.69% 44.83%
Invested Capital Q/Q Growth
20.71% 42.50% -64.50% -119.17% 50.64% 5.53% -7.55% -45.12% 1.08% 30.97% -11.55%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
68.24% 68.71% 66.13% 67.88% 69.18% 70.66% 67.17% 67.11% 70.16% 69.81% 69.26%
EBITDA Margin
-30.96% -28.41% -24.54% -29.26% -19.45% -16.15% -16.50% -18.42% -8.06% -10.64% -2.92%
Operating Margin
-40.76% -39.59% -37.01% -41.16% -30.73% -28.34% -24.66% -29.59% -19.21% -21.42% -13.44%
EBIT Margin
-38.75% -36.81% -33.32% -37.77% -27.37% -24.68% -21.33% -25.77% -15.43% -17.94% -9.96%
Profit (Net Income) Margin
-38.79% -36.39% -34.26% -38.15% -27.84% -24.99% -21.82% -26.36% -15.91% -18.50% -10.64%
Tax Burden Percent
100.10% 98.86% 102.81% 101.01% 101.73% 101.26% 102.29% 102.29% 103.13% 103.12% 106.85%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)
-26.53% -58.52% -29.58% -30.30% -30.32% -30.38% -29.27% -29.18% -26.47% -25.78% -22.64%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)
-16.45% -27.96% -17.27% -19.95% -15.60% -15.00% -13.28% -16.95% -10.61% -12.56% -7.03%
Return on Assets (ROA)
-16.47% -27.64% -17.76% -20.15% -15.87% -15.19% -13.58% -17.33% -10.95% -12.95% -7.51%
Return on Common Equity (ROCE)
-26.40% -38.05% -29.44% -30.17% -30.22% -30.31% -29.22% -29.14% -26.45% -25.77% -22.64%
Return on Equity Simple (ROE_SIMPLE)
-26.66% -33.22% 0.00% -32.16% -31.47% -30.96% 0.00% -29.19% -26.10% -25.23% 0.00%
Net Operating Profit after Tax (NOPAT)
-25 -26 -26 -29 -25 -25 -23 -28 -20 -23 -15
NOPAT Margin
-28.53% -27.71% -25.91% -28.82% -21.51% -19.84% -17.26% -20.71% -13.45% -14.99% -9.41%
Net Nonoperating Expense Percent (NNEP)
-3.49% -2.94% -1.66% -1.83% -1.48% -1.35% -1.25% -1.54% -0.73% -1.11% -0.40%
Return On Investment Capital (ROIC_SIMPLE)
- - -5.74% - - - -5.09% - - - -3.18%
Cost of Revenue to Revenue
31.76% 31.29% 33.87% 32.12% 30.82% 29.34% 32.83% 32.89% 29.84% 30.19% 30.74%
SG&A Expenses to Revenue
23.85% 24.09% 22.52% 23.56% 22.11% 21.34% 19.92% 19.78% 19.46% 20.52% 18.57%
R&D to Revenue
27.09% 27.47% 27.11% 29.22% 25.31% 24.10% 23.76% 25.38% 22.78% 21.61% 20.95%
Operating Expenses to Revenue
109.00% 108.30% 103.14% 109.05% 99.91% 99.00% 91.83% 96.70% 89.37% 91.23% 82.70%
Earnings before Interest and Taxes (EBIT)
-33 -34 -33 -38 -32 -31 -28 -35 -22 -27 -16
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-27 -26 -24 -30 -22 -20 -22 -25 -12 -16 -4.69
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
8.69 6.22 6.88 6.50 10.07 9.61 12.15 9.69 9.87 7.06 10.02
Price to Tangible Book Value (P/TBV)
8.69 6.22 6.89 6.50 10.87 10.36 13.10 10.45 10.61 7.58 10.73
Price to Revenue (P/Rev)
13.71 8.60 8.62 7.45 10.86 9.58 11.44 8.36 8.36 5.73 8.02
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
12.02 7.16 7.27 6.12 9.69 8.51 10.42 7.40 7.42 4.86 7.15
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 1,229.50 717.84 1,011.39 121.06 116.96 115.72
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-1.07 -1.07 -1.04 -1.12 -1.07 -1.06 -1.08 -1.14 -1.09 -1.08 -1.08
Leverage Ratio
1.48 1.68 1.44 1.56 1.57 1.62 1.70 1.76 1.74 1.80 1.83
Compound Leverage Factor
1.48 1.68 1.44 1.56 1.57 1.62 1.70 1.76 1.74 1.80 1.83
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.50% 0.40% 0.33% 0.25% 0.17% 0.11% 0.04% 0.03% -0.01% -0.05% -0.02%
Common Equity to Total Capital
99.50% 99.60% 99.67% 99.75% 99.84% 99.89% 99.96% 99.97% 100.01% 100.05% 100.02%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
11.07 7.88 7.37 6.13 9.28 7.76 8.93 6.69 7.31 5.10 7.32
Noncontrolling Interest Sharing Ratio
0.50% 34.99% 0.49% 0.43% 0.34% 0.26% 0.18% 0.14% 0.08% 0.03% 0.01%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
3.15 3.06 2.68 2.44 2.31 2.28 2.08 1.96 2.03 1.99 1.98
Quick Ratio
3.01 2.93 2.56 2.32 2.18 2.17 1.96 1.85 1.93 1.89 1.88
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
9.17 -24 -2.93 -1.94 -24 -11 -19 -47 -3.74 -21 -11
Operating Cash Flow to CapEx
-195.20% -577.22% 0.62% 2,527.91% -1,490.81% -51.25% 51.92% 243.84% 265.24% -402.04% 909.64%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.42 0.76 0.52 0.53 0.57 0.61 0.62 0.66 0.69 0.70 0.71
Accounts Receivable Turnover
6.21 6.94 4.98 6.95 6.92 6.78 5.53 6.82 7.58 6.98 6.33
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
18.31 24.74 25.63 25.37 22.12 20.44 18.99 16.92 17.78 17.97 17.48
Accounts Payable Turnover
33.65 65.65 44.68 39.23 54.80 34.45 31.32 38.59 52.66 39.93 43.25
Days Sales Outstanding (DSO)
58.75 52.61 73.34 52.54 52.74 53.83 65.99 53.54 48.15 52.30 57.66
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
10.85 5.56 8.17 9.31 6.66 10.59 11.66 9.46 6.93 9.14 8.44
Cash Conversion Cycle (CCC)
47.91 47.05 65.18 43.23 46.08 43.23 54.33 44.08 41.22 43.16 49.22
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
-34 -19 -32 -70 -35 -33 -35 -51 -50 -35 -39
Invested Capital Turnover
-17.67 -17.74 -17.26 -6.75 -11.97 -16.90 -14.09 -8.37 -12.63 -16.74 -16.07
Increase / (Decrease) in Invested Capital
-34 -1.90 -23 -27 -0.78 -13 -3.16 19 -16 -2.15 -3.70
Enterprise Value (EV)
3,583 2,342 2,585 2,324 3,961 3,739 4,917 3,738 3,974 2,739 4,245
Market Capitalization
4,087 2,814 3,063 2,829 4,436 4,210 5,396 4,225 4,478 3,232 4,758
Book Value per Share
$5.01 $4.76 $4.65 $4.52 $4.51 $4.43 $4.45 $4.32 $4.46 $4.46 $4.59
Tangible Book Value per Share
$5.01 $4.76 $4.65 $4.52 $4.18 $4.11 $4.13 $4.01 $4.15 $4.15 $4.28
Total Capital
473 454 447 436 441 439 444 436 454 458 475
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
-507 -474 -479 -506 -476 -471 -479 -487 -504 -493 -514
Capital Expenditures (CapEx)
8.36 4.14 1.93 0.89 1.18 3.91 7.36 7.95 4.38 2.84 1.88
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-110 -99 -113 -153 -150 -153 -168 -194 -196 -187 -194
Debt-free Net Working Capital (DFNWC)
397 374 366 353 326 318 312 293 308 305 320
Net Working Capital (NWC)
397 374 366 353 326 318 312 293 308 305 320
Net Nonoperating Expense (NNE)
8.84 8.09 8.24 9.50 7.29 6.38 5.97 7.65 3.58 5.33 1.97
Net Nonoperating Obligations (NNO)
-507 -474 -479 -506 -476 -471 -479 -487 -504 -493 -514
Total Depreciation and Amortization (D&A)
6.71 7.83 8.67 8.66 9.12 11 6.33 9.95 11 11 11
Debt-free, Cash-free Net Working Capital to Revenue
-36.92% -30.30% -31.74% -40.32% -36.72% -34.79% -35.57% -38.35% -36.51% -33.24% -32.69%
Debt-free Net Working Capital to Revenue
133.07% 114.46% 102.94% 92.98% 79.66% 72.45% 66.06% 58.02% 57.54% 54.10% 53.85%
Net Working Capital to Revenue
133.07% 114.46% 102.94% 92.98% 79.66% 72.45% 66.06% 58.02% 57.54% 54.10% 53.85%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.35) ($0.35) ($0.35) ($0.40) ($0.33) ($0.31) ($0.28) ($0.35) ($0.23) ($0.27) ($0.17)
Adjusted Weighted Average Basic Shares Outstanding
94.10M 94.47M 94.57M 96.35M 97.18M 97.88M 98.10M 100.79M 101.45M 102.15M 102.19M
Adjusted Diluted Earnings per Share
($0.35) ($0.35) ($0.35) ($0.40) ($0.33) ($0.31) ($0.28) ($0.35) ($0.23) ($0.27) ($0.17)
Adjusted Weighted Average Diluted Shares Outstanding
94.10M 94.47M 94.57M 96.35M 97.18M 97.88M 98.10M 100.79M 101.45M 102.15M 102.19M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
95.04M 95.71M 96.23M 97.59M 98.87M 99.84M 100.84M 101.63M 102.73M 103.48M 104.63M
Normalized Net Operating Profit after Tax (NOPAT)
-25 -26 -26 -29 -25 -25 -23 -28 -20 -23 -15
Normalized NOPAT Margin
-28.53% -27.71% -25.91% -28.82% -21.51% -19.84% -17.26% -20.71% -13.45% -14.99% -9.41%
Pre Tax Income Margin
-38.75% -36.81% -33.32% -37.77% -27.37% -24.68% -21.33% -25.77% -15.43% -17.94% -9.96%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Frequently Asked Questions About Braze's Financials

When does Braze's fiscal year end?

According to the most recent income statement we have on file, Braze's financial year ends in January. Their financial year 2025 ended on January 31, 2025.

How has Braze's net income changed over the last 5 years?

Braze's net income appears to be on an upward trend, with a most recent value of -$104.05 million in 2025, rising from -$31.81 million in 2020. The previous period was -$130.43 million in 2024.

What is Braze's operating income?
Braze's total operating income in 2025 was -$122.16 million, based on the following breakdown:
  • Total Gross Profit: $410.22 million
  • Total Operating Expenses: $532.38 million
How has Braze revenue changed over the last 5 years?

Over the last 5 years, Braze's total revenue changed from $96.36 million in 2020 to $593.41 million in 2025, a change of 515.8%.

How much debt does Braze have?

Braze's total liabilities were at $396.25 million at the end of 2025, a 8.1% increase from 2024, and a 283.1% increase since 2021.

How much cash does Braze have?

In the past 4 years, Braze's cash and equivalents has ranged from $28.51 million in 2021 to $478.94 million in 2022, and is currently $83.06 million as of their latest financial filing in 2025.

How has Braze's book value per share changed over the last 5 years?

Over the last 5 years, Braze's book value per share changed from 0.00 in 2020 to 4.59 in 2025, a change of 458.9%.

Remove Ads


This page (NASDAQ:BRZE) was last updated on 4/15/2025 by MarketBeat.com Staff
From Our Partners